Trial Profile
Study to Determine the Persistence and Adherence to Teriparatide treatment in Taiwanese patients with Osteoporosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 10 Apr 2018 New trial record